Literature DB >> 19793081

Invasive non-typhoidal Salmonella in Mozambican children.

Inácio Mandomando1, Eusébio Macete, Betuel Sigaúque, Luis Morais, Llorenç Quintó, Jahit Sacarlal, Mateu Espasa, Xavier Vallès, Quique Bassat, Pedro Aide, Tacilta Nhampossa, Sonia Machevo, Joaquim Ruiz, Ariel Nhacolo, Clara Menéndez, Karen L Kotloff, Anna Roca, Myron M Levine, Pedro L Alonso.   

Abstract

OBJECTIVE: To describe the epidemiology and clinical presentation of invasive non-typhoidal Salmonella (NTS) in Mozambique.
METHODOLOGY: We analysed the epidemiology, clinical presentation and serotype distribution of invasive NTS among Mozambican children admitted to the Manhiça District Hospital between May 2001 and April 2006.
RESULTS: A total of 401 NTS cases were analysed; the median age was 16 months [interquartile range (IQR): 10-24]. Fever, cough and increased respiratory rate were the most common symptoms reported, while diarrhoea was present in only 29%. In the univariate analysis, invasive NTS was associated with age, fever, diarrhoea, increased respiratory rate, splenomegaly, hepatomegaly, severe malnutrition, and severe anaemia. Young age, severe malnutrition, diarrhoea and pneumonia were independent risk factors of death. S. typhimurium (66%), and S. enteritidis (25%) were the most frequent serotypes, with incidence rates of 240.4 and 108.6 per 100,000 child years among infants for S. typhimurium and S. enteritidis, respectively; and no significant differences were found regarding their clinical presentation. Resistance to ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole was high for both S. typhimurium and S. enteritidis.
CONCLUSIONS: Clinical presentation of invasive NTS was non-specific and similar to that of other infections, with some factors being associated with NTS. Antibiotic resistance was very common to currently recommended and available antibiotics for suspected sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793081     DOI: 10.1111/j.1365-3156.2009.02399.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  42 in total

Review 1.  Diagnostics for invasive Salmonella infections: Current challenges and future directions.

Authors:  Jason R Andrews; Edward T Ryan
Journal:  Vaccine       Date:  2015-04-30       Impact factor: 3.641

2.  TTSS2-deficient hha mutant of Salmonella Typhimurium exhibits significant systemic attenuation in immunocompromised hosts.

Authors:  Vikalp Vishwakarma; Niladri Bhusan Pati; Shilpa Ray; Susmita Das; Mrutyunjay Suar
Journal:  Virulence       Date:  2014-01-08       Impact factor: 5.882

Review 3.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 4.  Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Authors:  Raphael Simon; Myron M Levine
Journal:  Hum Vaccin Immunother       Date:  2012-02-28       Impact factor: 3.452

5.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

Authors:  Clarissa Valim; Rushdy Ahmad; Miguel Lanaspa; Yan Tan; Sozinho Acácio; Michael A Gillette; Katherine D Almendinger; Danny A Milner; Lola Madrid; Karell Pellé; Jaroslaw Harezlak; Jacob Silterra; Pedro L Alonso; Steven A Carr; Jill P Mesirov; Dyann F Wirth; Roger C Wiegand; Quique Bassat
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

6.  Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

Authors:  Sharon M Tennant; Jin-Yuan Wang; James E Galen; Raphael Simon; Marcela F Pasetti; Orit Gat; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

7.  Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.

Authors:  Raphael Simon; Sharon M Tennant; Jin Y Wang; Patrick J Schmidlein; Andrew Lees; Robert K Ernst; Marcela F Pasetti; James E Galen; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

Review 8.  Typhoidal and non-typhoidal Salmonella infections in Africa.

Authors:  S I Smith; A Seriki; A Ajayi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-25       Impact factor: 3.267

9.  Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali.

Authors:  Sharon M Tennant; Souleymane Diallo; Haim Levy; Sofie Livio; Samba O Sow; Milagritos Tapia; Patricia I Fields; Matthew Mikoleit; Boubou Tamboura; Karen L Kotloff; James P Nataro; James E Galen; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2010-03-09

10.  Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies.

Authors:  George Mtove; Ben Amos; Lorenz von Seidlein; Ilse Hendriksen; Abraham Mwambuli; Juma Kimera; Rajabu Mallahiyo; Deok Ryun Kim; R Leon Ochiai; John D Clemens; Hugh Reyburn; Stephen Magesa; Jacqueline L Deen
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.